C2H-20514-16853
2 vaccinations
4 coded responses
24 check-ins
4 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 497 / MI
- Registered
- 2021-03-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-03
Dose 1 — Moderna
-
2021-03-04
Registered in v-safe
- 2021-03-04
- 2021-03-05
-
2021-03-06
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: FairFree text: A running nose but I have been spending a lot of time outdoors cross country skiing so it may just be irritated from the cold.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-07
- 2021-03-09
- 2021-03-12
- 2021-03-17
- 2021-03-24
-
2021-03-30
Dose 2 — Moderna
- 2021-03-30
-
2021-03-31
Survey response — days 1–6 daily, dose 2MedDRA: Ocular discomfort — Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Pressure over my eyes but not to the extent I would call it a headache.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
-
2021-04-13
Survey response — day 14, dose 2MedDRA: Injection site infection — Feeling: GoodFree text: While this is minor, now two weeks after my injection I seem to have a small infection at the injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-20
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-06-29
- 2021-09-28
-
2022-04-01
Survey response — 12 months, dose 2MedDRA: Dermatitis allergic, Nasopharyngitis, Office visit, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Severe cold symptoms but I tested negative for COVID. I also had a case of allergic dermatitis of unknown origin. · Healthcare visit (other): Appointment with an internistMedDRA releases: 2024-11 · check-in free text available
-
2022-04-01
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-04-05
-
2022-04-07
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Moderna | |
| 2 | 2021-03-30 | Moderna |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): A running nose but I have been spending a lot of time outdoors cross country skiing so it may just be irritated from the cold.
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Pressure over my eyes but not to the extent I would call it a headache.
Release 7 — day 14, dose 2
Symptoms: While this is minor, now two weeks after my injection I seem to have a small infection at the injection site.
Release 11 — 12 months, dose 2
Symptoms: Severe cold symptoms but I tested negative for COVID. I also had a case of allergic dermatitis of unknown origin.
Healthcare visit (other): Appointment with an internist
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Dermatitis allergic | · | · | ✓ |
| SD | Injection site infection | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Ocular discomfort | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release